The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1493
ISSUE1493
April 25, 2016
Mifepristone (Mifeprex) Label Changes
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Mifepristone (Mifeprex) Label Changes
April 25, 2016 (Issue: 1493)
The FDA has approved several significant changes in
the labeling of mifepristone (Mifeprex – Danco), an oral
antiprogestin that has been used in the US for more than
15 years for termination of intrauterine pregnancy. It
has generally been used...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.